Welcome to the February edition of our newsletter! Bringing you our latest discoveries in high-throughput screening, genomic and cellular analysis, colony selection, and microplate detection. Visit us at: moleculardevices.com
SLAS New Matter Podcast: Inside the Minds of SLAS Scientists
Listen in as our Sr. Scientist, Oksana Sirenko, PhD, discusses the progress of our nearly 40 year journey— from our first microplate readers to automated 3D imaging—and clarifies how to conquer the challenges that can come with transitioning from 2D to 3D imaging and analysis. Dr. Sirenko also shares insights into some of the exciting collaborations we've been involved with in biologics, high-content imaging, stem cell technologies, lab automation, and more!
Introducing our all new CloneSelect® Imager FL, our next-generation imaging platform for automatic, day zero monoclonality assurance.
High-speed multichannel fluorescent imaging
Multichannel confluence and growth curves
Automated Monoclonality Report generation
“Label-free, gene-edited monoclonal imaging techniques can be a time-consuming and highly-subjective process,” said Dan O’Connor, Vice President, Drug Discovery, Molecular Devices. “By using multi-channel fluorescence, the CSI FL provides complete assurance that clonal cell lines for mAb production, drug screening, and cell and gene therapies came from a single gene-edited progenitor. The CSI FL offers high-speed imaging of banked cell lines with CRISPR-confirmed edits, helping to expedite the therapeutic discovery process while providing full audit trail regulatory reporting.”
We’re thrilled to be presenting several tutorials and poster sessions showcasing innovative technologies and solutions to automate your complex 3D biology workflows at SLAS2022, including:
New advancements in engineering next-generation organoids
New developments in automated workflows for 3D cell culture, monitoring, and high-content imaging
As 3D organoids continue to accelerate the fields of cancer research, neurobiology, stem cell research, and drug discovery, we expanded our organoids page with applications and assays for the following:
Brain organoids
Intestinal organoids
Lab automation for organoid screening workflow
Patient-derived organoids (tumoroids)
Pulmonary (lung) organoids
The new section enables scientists and researchers to learn more about various organoids, including the perks of automated workflows, and uncover gems in our Resources section.
Explore our comprehensive compliance solutions with industry-leading microplate readers and software. Combined with validation services and support, our solutions assure data integrity and compliance in GMP/GLP labs.
IQ/OQ/PM services preserve instrument documentation in a digital and compliant format
Software installation services verify and document that required components are installed to operational specifications
Software validation service supports FDA 21 CFR Part 11 guidelines
We're expanding operations in Europe to meet the growing demand for #3Dbiology #research.
Get all the details around our €800,000 grant from the Austrian Research Promotion Agency (FFG), the doubling of our R&D footprint in Salzburg, Austria, and additional customer support roles in Italy, Spain, and Portugal in our latest press release.
Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.